60 results
8-K
EX-99.1
BMRN
Biomarin Pharmaceutical Inc. - Registered Shares
24 Apr 24
BioMarin Reports Record Financial Results for the First Quarter 2024
4:07pm
engagement with the Food and Drug Administration to align on development programs in idiopathic short stature (ISS) and multiple genetic short
8-K
EX-3.1
BMRN
Biomarin Pharmaceutical Inc. - Registered Shares
21 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:06pm
or engagement, to pledge its credit, or to render it liable for any purpose or for any amount.
8.3 Stock Certificates
The shares of the corporation shall
8-K
EX-3.1
zyv iw2czsr
18 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
qjj642b0
23 Oct 19
BioMarin Announces Third Quarter 2019 Financial Results
4:17pm
8-K
EX-99.1
gg5htwdtntjih
25 Oct 18
Results of Operations and Financial Condition
4:15pm
8-K
EX-3.1
390i83kbt yevf1
24 Sep 18
Amendments to Articles of Incorporation or Bylaws
5:16pm
8-K
EX-1.1
ds9ynvcdjyfkx
23 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-5.1
11pgmw9xe6t8g4
23 Jan 15
Entry into a Material Definitive Agreement
12:00am
S-8
EX-5.1
dmflxxji
14 Jan 15
Registration of securities for employees
12:00am
8-K
EX-5.1
coosg8
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
34d 48s3nfuvztos
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
kkyi7c h9
11 Oct 13
BioMarin Announces Proposed Offering of $300 Million of Senior Subordinated Convertible Notes
12:00am